Dr. Sanjog Rawtani, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Avenue, Suite 400/500. Third Floor. West Wing, Washington Dc, DC 20010 Phone: 202-699-5785 |
News Archive
Cancer Research UK has added the 1000th clinical trial to its award winning patient information website, CancerHelp UK, on the 10th anniversary of the launch of its clinical trials database today.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Sumatriptan Succinate Injection, USP, in two dosage strengths.
For college athletes, having attention deficit hyperactivity disorder (ADHD) may be linked to increased symptoms, and longer recovery time from concussions, according to a preliminary study released today that will be presented at the American Academy of Neurology Sports Concussion Conference in Indianapolis July 26-28.
Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for Jevtana® (cabazitaxel) Injection in combination with prednisone for the treatment of patients with metastatic hormone-refractory prostate cancer (mHRPC) previously treated with a docetaxel-containing treatment regimen.
New research by an international team including Keck Medicine of USC scientists is bringing the origins of ovarian cancer into sharper focus.
› Verified 8 days ago